ArticleCurrent oncology (Toronto, Ont.)2024

Prognostic Impact of Histologic Subtype and Divergent Differentiation in Patients with Metastatic Urothelial Carcinoma Treated with Enfortumab Vedotin: A Multicenter Retrospective Study.

Akinori Minato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.